Every patient considering breast implant surgery in Gurgaon deserves a conversation about risk that is based on published evidence rather than reassurance. Risk in breast augmentation surgery is real, measurable, and in large part manageable, but only when the patient understands what the specific risks are, how common each one actually is, and what the data shows about outcomes across the major published studies. General statements that breast implant surgery is safe are true but incomplete: the useful question is not whether there is risk but what that risk consists of at a quantitative level.
This guide addresses each of the clinically significant risks associated with breast implant surgery in Gurgaon with specific data where it exists, explains how each risk is managed at Artemis Hospital, and places the risk picture in the context of the long-term outcome data that large post-approval studies have produced. The goal is that patients arrive at the consultation informed rather than simply reassured.
Book a consultation with Dr. Pradeep Kumar Singh at Artemis Hospital, Gurugram, or call +91 82879 23924 to discuss breast implant surgery in Gurgaon and whether it is right for you.
Capsular Contracture: The Most Common Complication of Breast Implant Surgery in Gurgaon
Capsular contracture is the most frequently occurring complication of breast implant surgery in Gurgaon and in the global published literature on breast augmentation. When a foreign object is placed inside the body, the immune system responds by forming a fibrous capsule of scar tissue around it. This is a normal biological response, and the thin, soft capsule that forms around a well-placed implant is not a complication. Capsular contracture occurs when this capsule becomes abnormally thick and contracts, compressing the implant and causing the breast to feel firm, lose its natural shape, or become painful.
The FDA’s ten-year post-approval data for cohesive silicone gel implants reports capsular contracture rates of approximately 14 per cent for primary augmentation patients at ten years, a figure that varies across different studies depending on implant type, placement, and surgical technique. Submuscular implant placement, where the implant is positioned beneath the pectoral muscle rather than between the muscle and breast tissue, consistently produces lower capsular contracture rates than subglandular placement across all the major studies. At Artemis Hospital, submuscular or dual-plane placement is used in the majority of breast implant surgery Gurgaon cases for this reason.
Capsular contracture is graded on the Baker scale from I (normal soft breast) to IV (hard, painful, visibly distorted breast). Grade I and II contractures do not require intervention. Grade III and IV contractures are typically addressed surgically through capsulotomy, which releases the contracted capsule, or capsulectomy combined with implant replacement.
Implant Rupture: What the Ten-Year Data Shows
Implant rupture is a risk that exists across the lifespan of every breast implant, and the published rupture data provides a precise picture of what patients can expect. The FDA’s ten-year post-approval study of cohesive silicone gel implants found a cumulative rupture rate of 7.8 per cent for primary augmentation patients at ten years, meaning that approximately 92 per cent of patients have an intact implant after a decade. The annual rupture rate is not uniform across time: implants are more likely to rupture in their second decade than their first as the shell ages.
The clinical challenge with silicone implant rupture is that it is frequently silent. The cohesive gel maintains its form even when the shell is breached, so the breast may look and feel unchanged. The FDA recommends MRI screening beginning five to six years after silicone implant placement and every two to three years thereafter, regardless of symptoms. This monitoring protocol is a non-negotiable component of breast implant surgery Gurgaon aftercare at Artemis Hospital, not an optional follow-up. When rupture is identified through imaging, surgical removal and replacement is planned.
Saline implant rupture is immediately apparent because the saline deflates and the breast loses volume visibly within days. While this makes detection simple, the rupture itself still requires surgical replacement.
Infection, Seroma and Wound Healing: Early Complication Rates
The early complications of breast implant surgery, typically defined as occurring within the first ninety days, include infection, seroma, and wound healing problems. Published data from large cohort studies report infection rates of one to two per cent for primary breast augmentation. Seroma, the accumulation of fluid around the implant in the immediate post-operative period, occurs in approximately one to two per cent of cases and is managed by drainage. Wound healing complications are less common and are significantly associated with smoking, poorly controlled diabetes, and steroid use.
At Artemis Hospital, infection risk is reduced through the application of a structured antimicrobial protocol, including prophylactic intraoperative antibiotics, a no-touch technique for implant handling, and nipple shield application during surgery. These measures are evidence-based and have been shown in published literature to reduce early infection rates in breast augmentation surgery.
BIA-ALCL: An Accurate Account of a Rare Risk
BIA-ALCL, or breast implant-associated anaplastic large cell lymphoma, is a rare immune-cell cancer that has been linked specifically to breast implants with highly textured surfaces. It is not a form of breast cancer. The global incidence reported in medical literature is approximately one in three thousand to one in thirty thousand patients with textured implants, a wide range that reflects varying implant types and surveillance intensity across different countries.
The key clinical fact is that BIA-ALCL is linked to implant surface texture, specifically to the macrotextured and salt-loss textured surfaces produced by certain manufacturers. Many of these implants have been withdrawn from markets globally. Smooth cohesive silicone implants, the type used in breast implant surgery in Gurgaon at Artemis Hospital, carry a negligible documented risk of BIA-ALCL. When BIA-ALCL is detected early, typically presenting as a late seroma, unilateral swelling, or a mass, it is highly treatable. Implant removal with total capsulectomy achieves complete remission in the majority of cases identified at an early stage.
Breast Implant Illness: What the Evidence Currently Shows
Breast implant illness (BII) refers to a collection of systemic symptoms, including fatigue, joint pain, cognitive difficulties, and skin changes, that some patients attribute to their breast implants. It is a subject of ongoing medical research, and the honest answer is that the evidence base is still developing. Several large epidemiological studies have not found a statistically significant association between silicone breast implants and systemic connective tissue disease or autoimmune conditions. However, the subjective experience reported by patients who describe BII is real and documented.
Published data show that approximately two-thirds of patients who undergo implant removal reporting BII experience meaningful resolution of their symptoms after explantation. This association does not confirm that the implants caused the symptoms, but it does confirm that removal is a valid option for patients whose symptoms are significantly affecting their quality of life and who have decided that the implants should be removed. At Artemis Hospital, explantation surgery for patients who wish to have their implants removed is performed with the same care as the original breast implant surgery in Gurgaon, including complete capsule assessment and removal where indicated.
Long-Term Outcome Data: What Patients Can Expect Over Ten Years
The most clinically meaningful context for risk is the long-term outcome data from large cohort studies. The FDA post-approval studies, which represent the most comprehensive long-term safety dataset for breast augmentation surgery globally, provide the following picture for primary augmentation patients at ten years:
| Outcome Measure | Ten-Year Data | Clinical Implication |
| Intact implant | Approximately 92 per cent of patients | The majority of implants remain intact at ten years with routine monitoring |
| Capsular contracture (Grade III or IV) | Approximately 14 per cent | Manageable surgically; submuscular placement reduces rate |
| Additional surgery for any reason | Approximately 20 per cent | Planned and unplanned revisions are a realistic expectation over ten years |
| High patient satisfaction | Consistently above 90 per cent in published surveys | Despite the known complication rates, the overwhelming majority of patients are satisfied |
The most important figure in this table is the last one. Despite the documented complication rates, patient satisfaction with breast implant surgery in Gurgaon and globally remains consistently above 90 per cent across the major long-term studies. This is because the majority of complications, when they occur, are identifiable and treatable, and the overall impact of the procedure on quality of life and body image is strongly positive for the majority of patients who meet the candidacy criteria for surgery.
Breast Implant Surgery Gurgaon at Artemis Hospital
Dr. Pradeep Kumar Singh performs breast augmentation surgery in Gurgaon at Artemis Hospital, a JCI and NABH-accredited facility in Sector 51, Gurugram. The complication data discussed in this guide is the same data that informs the clinical decisions made at every breast implant surgery consultation at Artemis Hospital: implant selection, placement technique, the monitoring schedule prescribed post-operatively, and the antimicrobial protocol used in theatre. His MCh in Plastic Surgery from SMS Medical College, Jaipur, and Fellowship in Advanced Aesthetic Surgery from St Louis Hospital, Paris, provide the clinical foundation for interpreting this evidence and applying it to each individual patient’s anatomy and risk profile. As Head of the Department of Plastic Surgery and a member of the Association of Plastic Surgeons of India, Dr. Pradeep Kumar Singh, MCh Plastic Surgery, Fellowship Paris, APSI Member, ensures that every patient who undergoes breast implant surgery in Gurgaon at Artemis Hospital does so with a complete and honest understanding of the risks and the outcome data.
Patients seeking breast implant surgery Gurgaon travel to Artemis Hospital from DLF Phase 2, DLF Phase 4, Golf Course Road, Magnolias, Sushant Lok, Sector 56, Nirvana Country, DLF Camelia, Ardee City, Sector 42, M3M Golf Estate, Palam Vihar, Greater Kailash, Defence Colony, Vasant Vihar, Jor Bagh, Gold Links, Shanti Niketan, Haus Khas, Anand Niketan, Gulmohar Park, Green Park, Vasant Kunj, and South Extension.
Frequently Asked Questions
What are the most common risks of breast implant surgery in Gurgaon?
The most common complication of breast implant surgery in Gurgaon is capsular contracture, occurring in approximately 14 per cent of primary augmentation patients at ten years. Implant rupture occurs in approximately 7.8 per cent of patients at ten years for cohesive silicone implants. Early complications, including infection and seroma, occur in one to two per cent of cases. Serious complications are less common but should be understood before proceeding with breast implant surgery in Gurgaon.
How long do breast implants last?
Breast implants are not lifetime devices, but the published data show that approximately 92 per cent of cohesive silicone implants are intact at ten years. Implants do not have a fixed expiration date, and they do not need to be replaced on a set schedule if they remain intact and asymptomatic. Routine monitoring through MRI or ultrasound from year five onwards is the appropriate approach for breast implant surgery in Gurgaon patients, rather than scheduled replacement.
Can breast implants be removed if I change my mind?
Yes. Breast implants can be removed at any time through explantation surgery. The procedure removes the implant and, where indicated, the surrounding capsule. After removal, the breast typically has less volume than before the original breast augmentation surgery and may have some degree of skin laxity depending on how long the implants were in place and the quality of the overlying skin. Some patients combine explantation with a breast lift to address the skin changes that follow implant removal.
What is the recovery time for breast implant surgery in Gurgaon?
Most patients return to desk work within seven to ten days of breast implant surgery in Gurgaon. A supportive surgical bra is worn continuously for the first four to six weeks. No lifting above shoulder height for the first two weeks. Full return to exercise is typically permitted from weeks six to eight, once the implant has settled and the pectoral muscle has adjusted to its new position. Implants sit higher than their final settled position in the first four to six weeks and drop progressively into their natural position over that period.
Risk Understood Is Risk Managed
The risk profile of breast implant surgery in Gurgaon is well-documented, the complication rates are quantifiable, and the majority of complications are identifiable and treatable when patients maintain the monitoring schedule. The long-term outcome data from large post-approval studies show that patient satisfaction remains above 90 per cent at ten years, which is the most meaningful measure of whether the procedure delivers what patients expect it to deliver. At Artemis Hospital, the goal is that every patient who proceeds with breast implant surgery in Gurgaon does so with a precise and complete understanding of both the risks and the outcomes that the published evidence supports.
Book now or call +91 82879 23924 to schedule your breast implant surgery consultation with Dr. Pradeep Kumar Singh at Artemis Hospital.
Or visit Artemis Hospital, Sector 51, Gurugram, Haryana 122001.
Read patient reviews at Dr. Pradeep Kumar Singh on Google.
Dr. Pradeep Kumar Singh: MCh Plastic Surgery, Fellowship Paris, APSI Member: Head of Plastic Surgery, Artemis Hospital, Sector 51, Gurugram.
